Abstract 3122: Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system

Abstract

Abstract Her4 (ErbB-4) and Her2/neu (ErbB-2) are receptor tyrosine kinases belonging to the Epidermal Growth Factor Receptor (EGFR) family. Crystal structures of EGFR and Her4 kinase domains have demonstrated kinase dimerization and activation through an allosteric mechanism. The kinase domains form an asymmetric dimer, where the C-lobe surface of one monomer contacts the N-lobe of the other monomer. In vitro studies of EGFR tyrosine kinase dimerization and activation were previously reported using a nickel-chelating lipid - liposome system, and we now demonstrate this system can be broadly applied to all other members of the EGFR family. Polyhistidine tagged-Her4, Her2/neu, and Her3 kinase domains are bound to these nickel-chelating lipid containing liposomes and are brought to a high local concentration, mimicking what happens to the full-length receptors in vivo following ligand binding. Addition of Nickel-liposomes to Her4 kinase domain results in a 40-fold activation in kinase specific activity and a marked enhancement in C-terminal tail autophosphorylation. Activation of Her4 shows a sigmoidal dependence on kinase concentration, consistent with a cooperative process that requires kinase dimerization. Her2/neu kinase activity is also activated by Nickel-liposomes, and further increases in Her2/neu activity are achieved by heterodimerization with either Her3 or Her4. The ability of Her3 and Her4 to heterodimerize and activate other family members is studied in vitro. Her3 kinase domain readily activates Her2/neu but is a poor activator of Her4, which differs from the prediction made by the asymmetric dimer model, and suggests that the mode of dimerization of Her3 needs to be further studied. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3122.